Mr. Fragiskatos, thank you very much for that question. I agree with you. It is a very important one and it is one that is very much on the minds of all Canadians.
You have referred to PPE. That's an important element. Clearly, vaccines are another very important element.
Let me speak to a third issue, which I think has become very clear to Canadians in the course of this pandemic, and that is biomanufacturing capacity here in Canada. We have fantastic researchers. We have fantastic life scientists in our amazing country. What we don't have enough of is the ability to actually manufacture the vaccines that they play a central role in developing. I'm thinking of Acuitas as an example, an amazing B.C. company that plays a key role in the development and the production of the Pfizer-BioNTech vaccine.
One of the things that our government is working on, in close collaboration with provinces and territories across the country, is stepping up our game and investing in biomanufacturing across the country, whether it is VIDO-InterVac in Saskatchewan, whether it is Medicago or whether it is the NRC. I think that's an effort that all of us will agree is important and that we need to continue down that path.